Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Apr 1;14(4):e241897.
doi: 10.1136/bcr-2021-241897.

Treatment-resistant priapism associated with long-term low-molecular-weight heparin

Affiliations
Case Reports

Treatment-resistant priapism associated with long-term low-molecular-weight heparin

David Bouchier-Hayes et al. BMJ Case Rep. .

Abstract

This case report summarises the case of a 56-year-old man with low-flow, ischaemic priapism requiring urgent insertion of a penile prosthesis following prophylactic anticoagulation with tinzaparin. Low-molecular-weight heparin (LMWH) has been proposed as a cause of ischaemic priapism, although reported cases of this are rare. This particular side effect of tinzaparin has been reported once in a case report in 2018, and there are scant other reports of LMWH-induced priapism. This case was refractory to the full treatment algorithm, including multiple aspirations, phenylephrine injection, cavernosal shunt and required transfer for implantation of a penile prosthesis. Only one other case of such a severe case of priapism has been documented, involving LMWH and warfarin. Documented evidence of possible causes of priapism are vital, given the rarity of this condition, the frequency of LMWH and the potentially devastating complications.

Keywords: haematology (drugs and medicines); urology.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Drainage of blood from corpora cavernosa, O2 of 3.99 kPa, CO2 of 12.4 kPa, pH of 6.98.
Figure 2
Figure 2
Passing biopsy gun through glans to create a shunt between corpus spongiosum and both corpora cavernosa.

References

    1. Burnett AL, Bivalacqua TJ. Priapism: current principles and practice. Urol Clin North Am 2007;34:631–42. 10.1016/j.ucl.2007.08.006 - DOI - PubMed
    1. Salonia A, Eardley I, Giuliano F, et al. . European association of urology guidelines on priapism. Eur Urol 2014;65:480–9. 10.1016/j.eururo.2013.11.008 - DOI - PubMed
    1. Kovac JR, Mak SK, Garcia MM, et al. . A pathophysiology-based approach to the management of early priapism. Asian J Androl 2013;15:20–6. 10.1038/aja.2012.83 - DOI - PMC - PubMed
    1. Broderick GA, Kadioglu A, Bivalacqua TJ, et al. . Priapism: pathogenesis, epidemiology, and management. J Sex Med 2010;7:476–500. 10.1111/j.1743-6109.2009.01625.x - DOI - PubMed
    1. Purnell J, Abdulla AN. Case report: ischemic priapism secondary to tinzaparin. Int J Impot Res 2018;30:62–4. 10.1038/s41443-017-0008-0 - DOI - PubMed

Publication types

LinkOut - more resources